Priority Aviation, Inc. (PJET)
New York City, NY, US
Priority One Jets, Inc. operates as a comprehensive aviation provider, delivering a broad spectrum of services that encompass on-demand air charters, exclusive jet membership programs, and aircraft acquisition and sales. Catering to diverse clientele, the company serves the needs of business aviation, leisure travelers, and governmental agencies alike. Its offerings extend to specialized jet sales and leasing solutions, including private jet sales, flexible leasing options, fractional ownership programs, and expert consultation on aircraft acquisition pricing. Furthermore, Priority One Jets provides a full suite of private jet support services such as bespoke concierge assistance, thorough aircraft management and maintenance, private helicopter charters, and precise flight monitoring and coordination. Additional specialized services include facilitating government travel, orchestrating air cargo charters, and offering critical personal security, medical transport, and rapid disaster evacuation services. Beyond passenger and private jet operations, the company excels in air cargo freight jet charters. These services support general freight forwarding and are particularly adept at transporting heavy and oversized items, including construction equipment, industrial machinery parts, and high-value commodities demanding secure, point-to-point delivery. They also handle aerospace equipment, provide crucial logistical support for peacekeeping operations, and manage the transport of hazardous materials. Further capabilities include time-critical parcel delivery, secure aircraft loading and docking procedures, and serving challenging remote origins and destinations, especially for the oil, automotive, and gas industries' equipment transportation needs. With a global footprint, Priority One Jets provides charter services connecting numerous premier destinations worldwide, including major hubs like New York City, Miami, Los Angeles, Las Vegas, London, Sydney, and popular luxury locales such as the Bahamas, Monaco, Istanbul, and Ibiza. Headquartered in New York, New York, the company maintains an international presence with additional operational centers spanning the Americas, Europe, and Asia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | -75.00% | +0.00% | +9,900.00% | +900.00% | -83.33% | -98.44% | -92.31% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%—
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+0.0% Q4'22: +75.0% (vs Q4'21)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%—
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%—
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%— Q4'22: +18.4% (vs Q4'21)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+25.3% Q4'22: +10.2% (vs Q4'21)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×-0.90× Q4'22: -1.88× (vs Q4'21)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Peter Minikes | Chief Executive Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PJET
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
